Fig. 1: Flow diagram of patients enrolled in DEFIFrance. | Bone Marrow Transplantation

Fig. 1: Flow diagram of patients enrolled in DEFIFrance.

From: Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

Fig. 1

HCT indicates haematopoietic cell transplantation, VOD/SOS, veno-occlusive disease/sinusoidal obstruction syndrome. *Twenty-two patients in total were excluded from the study analysis: 20 patients received defibrotide prior to the 15 July 2014 start date or were missing a treatment start date; two patients were included in the HARMONY study. †Thirty-three patients were not included in subpopulations: 30 patients had suspected but unconfirmed VOD/SOS; one patient received a liver and kidney transplant rather than HCT; one patient was treated for thrombotic microangiopathy; and one patient received defibrotide for the treatment of VOD/SOS, but data on whether the treatment was given post-HCT were missing. ‡Data on the severity of VOD/SOS were missing in four patients.

Back to article page